Video
Resource Library
Video
Poster
JUN 4, 2026
In vitro Profile of Elismetrep (T6)
A Potent and Highly Selective Blocker of the Migraine-Associated Channel TRPM8.
Read More
Poster
Poster
JUN 4, 2026
Exposure–Response Modeling (T101)
Predicts Improved Anti-Migraine Efficacy of Elismetrep with an Optimized Formulation Enabling Faster Drug Absorption
Read More
Poster
JUN 4, 2026
The Human Pharmacokinetics of Elismetrep (T34)
A TRPM8 Migraine-Associated Channel Blocker (MACB), are Well-Suited for a Migraine Therapeutic.
Read More
Presentation
MAY 8, 2026
TRPM8 Antagonism with Elismetrep: A Novel Approach for Treating Migraine
As presented at the 2026 American Academy of Neurology Annual Meeting in April 2026.
Read More